Company Watch: Open Orphan could realise £20 million in first non-core asset IPO

Co-founder Cathal Friel has indicated that a series of spinouts could unlock £750 million for shareholders in the Dublin-based pharma company

Cathal Friel: planning an IPO for Open Orphan Pic: Fergal Phillips

Open Orphan, the Dublin-listed pharmaceutical services company run by Cathal Friel, will launch an initial public offering (IPO) of one of its non-core assets in June in a move that could raise more than £20 million.

It is likely to be the beginning of a busy period of stock market listings for Friel, who has in the past identified a further three non-core assets that could be publicly listed.

In a recent investor presentation, Friel ...